Penn Highlands Huntingdon | |
1225 Warm Springs Ave, Huntingdon, Pennsylvania 16652 | |
(814) 643-2290 | |
Name | Penn Highlands Huntingdon |
---|---|
Type | Acute Care Hospital |
Location | 1225 Warm Springs Ave, Huntingdon, Pennsylvania |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 390056 |
NPI Number | 1427230234 |
Organization Name | J C BLAIR MEMORIAL HOSPITAL |
Doing Business As | PENN HIGHLANDS HUNTINGDON |
Address | 1225 Warm Springs Ave, Huntingdon, PA 16652 |
Hospital Type | General Acute Care Hospital |
Phone Number | 814-643-2290 |
News Archive
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson's – a brain scan that can be used to select the right people for clinical trials.
› Verified 5 days ago
NPI Number | 1427269174 |
Organization Name | J C BLAIR MEMORIAL HOSPITAL |
Doing Business As | PENN HIGHLANDS HUNTINGDON |
Address | 1225 Warm Springs Ave, Huntingdon, PA 16652 |
Hospital Type | General Acute Care Hospital |
Phone Number | 814-643-2290 |
News Archive
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson's – a brain scan that can be used to select the right people for clinical trials.
› Verified 5 days ago
NPI Number | 1609087352 |
Organization Name | J C BLAIR MEMORIAL HOSPITAL |
Address | 1225 Warm Springs Ave, Huntingdon, PA 16652 |
Hospital Type | General Acute Care Hospital |
Phone Number | 814-643-2290 |
News Archive
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson's – a brain scan that can be used to select the right people for clinical trials.
› Verified 5 days ago
NPI Number | 1790996445 |
Organization Name | J C BLAIR MEMORIAL HOSPITAL |
Address | 1225 Warm Springs Ave, Huntingdon, PA 16652 |
Hospital Type | General Acute Care Hospital |
Phone Number | 814-643-2290 |
News Archive
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson's – a brain scan that can be used to select the right people for clinical trials.
› Verified 5 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations.
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.
From today forward, researchers and drug companies have a new tool in the search for better treatments for Parkinson's – a brain scan that can be used to select the right people for clinical trials.
› Verified 5 days ago
Penn Highlands Huntingdon Acute Care Hospital Location: 1225 Warm Springs Ave, Huntingdon, Pennsylvania 16652 Phone: (814) 643-2290 |